Katherine Stueland
Chief Executive Officer presso GENEDX HOLDINGS CORP.
Patrimonio netto: 608 953 $ in data 31/03/2024
Profilo
Katherine A.
Stueland is currently the President, Chief Executive Officer & Director at GeneDx Holdings Corp.
She is also the President & Chief Executive Officer at GeneDx LLC and a Director at Cancan Health.
Previously, she served as the President & Chief Executive Officer of GeneDx, Inc. and as a Director at the Rivkin Center for Ovarian Cancer.
She was the VP-Corporate Communications & Investor Relations at Dendreon Corp.
from 2009 to 2012.
From 2014 to 2021, she worked as the Chief Commercial Officer at Invitae Corp.
Additionally, she briefly served as the Principal at Vivo Communications, LLC in 2013.
Ms. Stueland completed her undergraduate degree at Miami University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 18/03/2024 | 66 698 ( 0.26% ) | 608 953 $ | 31/03/2024 |
Posizioni attive di Katherine Stueland
| Società | Posizione | Inizio |
|---|---|---|
| GENEDX HOLDINGS CORP. | Chief Executive Officer | 29/04/2022 |
| Cancan Health | Director/Board Member | - |
GeneDx LLC
 GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a leader in clinical genomics and rare disease. The private company is based in Stamford, CT. GeneDx was founded in 2000. GeneDx is known for its unparalleled database, deep clinical knowledge, and expertise in variant interpretation. The CEO is Katherine A. Stueland. | Chief Executive Officer | 01/06/2021 |
Precedenti posizioni note di Katherine Stueland
| Società | Posizione | Fine |
|---|---|---|
| INVITAE CORPORATION | Investor Relations Contact | 01/10/2016 |
Vivo Communications, LLC
 Vivo Communications, LLC Specialty TelecommunicationsCommunications Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA. | Corporate Officer/Principal | 01/12/2013 |
| DENDREON CORPORATION | Investor Relations Contact | 01/06/2012 |
GeneDx, Inc.
 GeneDx, Inc. Medical/Nursing ServicesHealth Services GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD. | Chief Executive Officer | - |
Rivkin Center for Ovarian Cancer
 Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Director/Board Member | - |
Formazione di Katherine Stueland
| Miami University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INVITAE CORPORATION | Health Services |
| GENEDX HOLDINGS CORP. | Health Services |
| Aziende private | 6 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
GeneDx, Inc.
GeneDx, Inc. Medical/Nursing ServicesHealth Services GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD. | Health Services |
Rivkin Center for Ovarian Cancer
Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Commercial Services |
| Cancan Health | |
Vivo Communications, LLC
Vivo Communications, LLC Specialty TelecommunicationsCommunications Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA. | Communications |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a leader in clinical genomics and rare disease. The private company is based in Stamford, CT. GeneDx was founded in 2000. GeneDx is known for its unparalleled database, deep clinical knowledge, and expertise in variant interpretation. The CEO is Katherine A. Stueland. | Health Services |
- Borsa valori
- Insiders
- Katherine Stueland
